Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Future directions for precision oncology in prostate cancer

3 Jun 2022

Abstract excerpt

Clinical genomic testing is becoming routine in prostate cancer, as biomarker-driven therapies such as poly-ADP ribose polymerase (PARP) inhibitors and anti-PD1 immunotherapy are now approved for select men with castration-resistant prostate cancer harboring alterations in DNA repair genes. Challenges for precision medicine in prostate cancer include an overall low prevalence of actionable genomic alterations and...

Source

Identifiers

PMID: 35657153
DOI: 10.1002/pros.24354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Future directions for precision oncology in prostate cancerPMID 35657153Read ↗

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.Semantic proximity Read ↗

Precision medicine for advanced prostate cancer.Semantic proximity Read ↗

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolutionSemantic proximity Read ↗

Clinical variability and molecular heterogeneity in prostate cancerSemantic proximity Read ↗

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic FrontiersSemantic proximity Read ↗

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingSemantic proximity Read ↗

New Strategies in Prostate Cancer: Translating Genomics into the ClinicSemantic proximity Read ↗

The Genomic Landscape of Prostate CancerSemantic proximity Read ↗

Translational and clinical implications of the genetic landscape of prostate cancer.Semantic proximity Read ↗

Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.Semantic proximity Read ↗

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerSemantic proximity Read ↗

Advancing Precision Medicine for Prostate Cancer Through GenomicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.